GO
Loading...

Bristol-Myers Squibb Co

More

  • Midday Glance: Pharmaceuticals companies Thursday, 15 Jan 2015 | 1:59 PM ET

    Baxter International Inc. fell$. 41 or. 6 percent, to $71.32. Bristol-Myers Squibb Co. fell $1.41 or 2.2 percent, to $61.54. Hospira fell$. 20 or. 3 percent, to $61.60.

  • Early Glance: Pharmaceuticals companies Thursday, 15 Jan 2015 | 11:00 AM ET

    Baxter International Inc. fell$. 26 or. 4 percent, to $71.47. Bristol-Myers Squibb Co. fell$. 57 or. 9 percent, to $62.38. Hospira fell$. 48 or. 8 percent, to $61.32.

  • Final Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $71.73. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $62.95. Hospira rose$. 04 or. 1 percent, to $61.80.

  • Midday Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 1:43 PM ET

    Baxter International Inc. fell$. 68 or. 9 percent, to $71.29. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $62.92. Hospira fell$. 45 or. 7 percent, to $61.31.

  • Early Glance: Pharmaceuticals companies Wednesday, 14 Jan 2015 | 10:41 AM ET

    Baxter International Inc. fell$. 56 or. 8 percent, to $71.41. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $62.92. Hospira rose$. 16 or. 3 percent, to $61.92.

  • *AstraZeneca sees $3.5 bln sales, analysts' numbers lower. *AstraZeneca shares up 1.5 percent. LONDON, Jan 14- AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost hopes for the closely watched product.

  • *AstraZeneca shares up 1.5 percent. LONDON, Jan 14- AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost hopes for the product. But AstraZeneca Chief Executive Pascal Soriot has made it a top priority and the company flagged Brilinta's...

  • Final Glance: Pharmaceuticals companies Tuesday, 13 Jan 2015 | 6:15 PM ET

    Baxter International Inc. fell$. 75 or 1.0 percent, to $71.97. Bristol-Myers Squibb Co. rose$. 94 or 1.5 percent, to $63.12. Hospira rose$. 21 or. 3 percent, to $61.76.

  • Midday Glance: Pharmaceuticals companies Tuesday, 13 Jan 2015 | 1:17 PM ET

    Baxter International Inc. fell$. 15 or. 2 percent, to $72.57. Bristol-Myers Squibb Co. rose $1.13 or 1.8 percent, to $63.31. Hospira rose$. 43 or. 7 percent, to $61.98.

  • Early Glance: Pharmaceuticals companies Tuesday, 13 Jan 2015 | 10:42 AM ET

    Baxter International Inc. rose$. 84 or 1.2 percent, to $73.56. Bristol-Myers Squibb Co. rose $1.22 or 2.0 percent, to $63.40. Hospira rose $1.15 or 1.9 percent, to $62.70.

  • Lightning Round: Sweet spot of the marketplace Monday, 12 Jan 2015 | 7:04 PM ET

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • 11 ways to play biotech Monday, 12 Jan 2015 | 6:59 PM ET

    Traders on CNBC's "Fast Money" outlined their strongest plays in the ever-volatile biotechnology space.

  • Your first trade for Tuesday Monday, 12 Jan 2015 | 6:23 PM ET

    The "Fast Money" traders give their final trades of the day.

  • US stocks end lower with crude; Alcoa reports Monday, 12 Jan 2015 | 4:08 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks dropped Monday after a second weekly loss.

  • *Foundation Medicine jumps; Roche to take majority stake. Oil prices continued their downward march and weighed on equities, with both Brent and U.S. crude down about 4 percent as Goldman Sachs slashed its short-term price forecasts and Gulf producers showed no signs of curbing output. "During this cycle, since the beginning of the precipitous selloff in the...

  • *Foundation Medicine jumps; Roche to take majority stake. Oil prices continued their downward march and helped weaken futures, with Brent down 3.8 percent to $48.20 and U.S. crude down 3.7 percent to $46.59 as Goldman Sachs slashed its short-term price forecasts and Gulf producers showed no signs of curbing output. "During this cycle, since the beginning of the...

  • *Foundation Medicine jumps; Roche to take majority stake. NEW YORK, Jan 12- U.S. stock index futures rose on Monday, after a two-week decline pushed the S&P 500 back into negative territory for the year, as investors anticipated the start of the corporate earnings season. *Alcoa is scheduled to post quarterly earnings after the closing bell, with financials JPMorgan...

  • Early movers: TIF, DLTR, CZR, MS, GM & more Monday, 12 Jan 2015 | 7:58 AM ET
    Trader on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures climb after two-week drop Monday, 12 Jan 2015 | 7:35 AM ET

    *Foundation Medicine jumps; Roche to take majority stake. NEW YORK, Jan 12- U.S. stock index futures rose on Monday, after a two-day decline pushed the S&P 500 back into negative territory for the year, as investors anticipated the start of the corporate earnings season. *Alcoa is scheduled to post quarterly earnings after the closing bell, with financials JPMorgan...

  • ZURICH/ LOS ANGELES Jan 12- Roche Holding will acquire a majority stake in molecular and genomic analysis business Foundation Medicine, it said on Monday, signalling its determination to expand in cancer immunotherapy by paying a hefty mark-up on the U.S. company's current price. The deal will help the world's largest maker of cancer drugs push ahead in...